The variability and durability of improvements in pain and physical function following Roux-en-Y gastric bypass (RYGB) or laparoscopic adjustable gastric banding (LAGB) are not well described.
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Bariatric surgery is effective at achieving and maintaining weight loss, and inducing remission or reducing severity of many comorbidities such as type 2 diabetes mellitus, hypertension, dyslipidemia, and depression. 8, 9 Although evidence of improvements in pain and physical function following bariatric surgery is increasing, the variability and durability of improvement have not been well described-with most studies limited by small sample size and follow-up of 1 year or less or by the study of obsolete surgical procedures. [10] [11] [12] This report examines pain and physical function outcomes in a large multisite cohort study with annual followup. The aim of the study was to evaluate changes in bodily and joint-specific pain and physical function, including perceived and objectively measured walking capacity in the first 3 years following bariatric surgery, and to identify factors associated with presurgery-to-postsurgery improvements.
Methods

Participants
The Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study is an observational study of 2458 adults who underwent an initial bariatric surgical procedure between March 14, 2006 , and April 24, 2009 , at 1 of 10 hospitals at 6 US clinical centers.
13, 14 The institutional review boards at each center and the data coordinating center approved the protocol and all participants provided written informed consent. LABS-2 had a target sample size of 2400 participants, based on anticipated loss to follow-up of 17% to 25% and the desire to detect small effect sizes for continuous outcomes (requires ≤1800 participants) and odds ratios (ORs) of at least 2.0 for categorical outcomes with 90% power (requires ≤2000 participants) for discrete outcomes in most circumstances.
Assessments were conducted by trained personnel within 30 days prior to scheduled surgery and annually following surgery. To be included, participants had to complete the baseline and at least 1 follow-up assessment within the first 3 postsurgery years (2221 participants; 91% with baseline data), with data collection ending October 2012 ( Figure 1 ).
Measures
The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) is a generic measure of functional health and wellbeing with proven validity, reliability, and sensitivity to change. 15 Two domain scores were examined: bodily pain, composed of 2 items that assess the magnitude of bodily pain and how much it interferes with activities; and physical function, composed of 10 items that assess whether health limits various activities. Norm-based methods were used to transform the scores to a mean (SD) of 50 (10) in the general US population. 16 Higher SF-36 scores indicate less pain or better
function. An increase of at least 5 points represents a clinically important improvement. 17 The 3 items specific to walking limitations were also examined. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) measures symptoms of hip and knee osteoarthritis. It has demonstrated reliability and validity and is sensitive to preintervention-to-postintervention changes. 18 This analysis used 2 scores per joint: pain, composed of 5 items that assess pain level during various activities; and function, composed of 17 items that assess difficulty performing various activities. Scores were transformed to a scale (0-100; lower scores indicate less pain and better function). 19 A decrease of at least 9.7 pain points and at least 9.3 function points represents a clinically important improvement.
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Participants reported history of back, hip, knee, and ankle surgery; use of pain medication (prescription or over-thecounter) for back, hip(s), knee(s), or ankle(s), in the past week; The 400-m Long-Distance Corridor Walk (LDCW) was used to objectively measure walking capacity. 21, 22 To minimize risk, participants were instructed to walk the 400-m course at their usual pace and to wear a heart rate monitor. After completion, participants were asked if they experienced back, hip, knee, or foot pain during the LDCW. Testing could be terminated prior to completion for safety reasons. Participants were ineligible to attempt the LDCW if they had a contraindication to exertion, had any of several cardiovascular risk factors (eg, hospitalized for myocardial infarction, underwent angioplasty, or saw a clinician for new or worsening chest pain in the past 3 months), needed a mobility aid other than a straight cane, or reported feeling unsafe. Participants were categorized as having a mobility deficit if they met the LDCW exclusion criteria or stopping criteria or exceeded 7 minutes to walk 400 m (which equates to a cardiorespiratory fitness level of <12 mL oxygen/kg/min, the minimal level deemed necessary to safely cross a traffic intersection). 23 A decrease of at least 24 seconds indicates a substantial improvement. 24 Heart rate, measured after a minimum of 5 minutes of seated rest, was used as a proxy for cardiovascular fitness.
Primary end points were clinically meaningful presurgeryto-postsurgery improvements in pain and function scores from the SF-36 Health Survey and 400-m walk time. Secondary end points were clinically meaningful improvements in the WOMAC and remission of mobility deficit.
Anthropometrics, Sociodemographics, and Health Indicators Anthropometric measurements followed standardized protocols. 8 Sociodemographics and smoking status were selfreported. Race was set to missing for participants who did not self-report as one or more of the following: white/Caucasian, black/African American, Asian, American Indian/Alaska Native, Native Hawaiian/other Pacific Islander. β-Blocker use was determined from the therapeutic class of self-reported prescribed medications. Diabetes and history of stroke, cardiovascular disease (CVD), asthma, sleep apnea, and venous edema with ulcerations were determined using laboratory values (eg, hemoglobin A 1c ), physical examination measures (eg, blood pressure), patient-reported medication use, comorbidity diagnoses from clinicians, and medical records review using standard definitions. 14 Due to lack of sleep studies following surgery, only baseline sleep apnea status was used in this analysis. Depressive symptoms in the past week were assessed using the Beck Depression Inventory (BDI) version 1.
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Higher BDI scores (range, 0-63) indicate greater depressive symptomatology.
Statistical Analysis
Analyses were conducted using SAS version 9.3. Potential selection bias was examined by comparing preoperative characteristics and presurgery-to-postsurgery percent weight loss of LABS-2 participants in the analysis sample (n = 2221) to those excluded (n = 237) using the The proportions of participants with clinically meaningful presurgery-to-postsurgery improvements based on SF-36 scores (among the total sample), WOMAC scores, and the LDCW time (among subgroups previously described) were calculated using established thresholds 17, 20, 24 with Poisson mixed models with robust error variance. An additional 12 to 23 patients whose baseline WOMAC scores did not meet the thresholds for clinically important improvement were excluded. Postsurgery remission of mobility deficit (among patients with a presurgery mobility deficit) was also calculated. Year-1 and year-3 proportions were compared using t statistic (eAppen-
Modeled percentages or means and 95% CIs, are reported. Summary statistics of observed data are reported online (eTables 2-3 [Supplement]).
Identifying Factors Related to Improvement
Poisson mixed models with robust error variance were used to identify factors related to clinically important presurgeryto-postsurgery improvements in SF-36 and WOMAC scores, LDCW time, and remission of mobility deficit in years 1, 2, and 3. Sex, race, baseline age, household income, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared), depressive symptoms, surgical procedure, presurgery-to-postsurgery smoking status, change in depressive symptoms, and percent weight change were in-cluded in all models as independent variables, with control for site. Baseline and presurgery-to-postsurgery change in bodily pain were also included as independent variables in models of physical function and LDCW outcomes. Baseline sleep apnea status, history of stroke, and postsurgery status of diabetes, asthma, venous edema with ulcerations, and CVD symptoms with consideration for baseline status (ie, current vs remitted/no symptoms in past 12 months, and no history) were also considered as independent variables and retained if statistically significant (P < .05). Adjusted relative risks (RRs), 95% CIs, and P values are reported. All reported P values are 2-sided; P <.05 was considered to be statistically significant.
Results
Participant Characteristics
This report includes 2221 of 2428 study participants (91%) with baseline data ( Figure 1 ; Table 1 ). Pain and function data were obtained in 2042 (84%) participants at year 1, 1794 (74%) at year 2, and 1724 (72%) at year 3. Participants who were excluded (n = 237) vs included (n = 2221) from the analysis sample were younger (median age, 41 vs 47 years) and had a lower household income, a higher proportion of current smokers (22% vs 12%), and a lower proportion of sleep apnea (43% vs 54%) (P value for all <.05). There was also a significant difference in site representation between participants who were excluded vs included. There were no other statistically significant differences in baseline characteristics, or in percent of weight loss from baseline at year 1, year 2, or year 3, controlling for baseline characteristics that differed by group (P value for all ≥.05).
RYGB was the most common surgical procedure (70.4%); one-fourth (25.0%) of patients underwent LAGB; and less than 5% underwent another procedure (sleeve gastrectomy, banded gastric bypass, or biliopancreatic diversion with duodenal switch). Median (IQR) percentage weight loss of baseline weight at year 1 was 30.5% (21.3%-37.5%), at year 2 it was 30.5% (21.3%-38.5%), and at year 3 it was 28.2% (19.8%-36.4%) overall. Following RYGB, percentage weight loss at year 1 was 34.1% (28.7%-39.2%), at year 2 it was 34.1% (27.7%-40.3%), and at year 3 it was 31.5% (24.8%-8.4%). Following LAGB, percentage weight loss at 1 year was 14.0% (9.7%-19.7%), at year 2 it was 16.1% (9.4%-23.0%), and at year 3 it was 16.2% (8.1%-23.1%).
Presurgery-to-Postsurgery Change in Pain and Physical Function
Following surgery, SF-36 scores were significantly higher for bodily pain (baseline, 39.9 [95% CI, 39. 3) , indicating improvements in the entire sample and specifically among participants with severe knee or hip pain or disability at baseline ( Table 2) . The degree to which back e Lower scores indicate less pain and better function on a 0-to 100-point scale.
f Excludes 4 of 633 due to missing baseline knee pain score.
g Excludes 1 of 500 due to missing baseline hip pain score.
h Excludes 6 of 633 due to missing baseline knee function score.
i Excludes 7 of 500 due to missing baseline hip function score.
j N = 1168; excludes participants who missed LDCW (n = 132), were ineligible or refused LDCW (n = 540), or did not answer pain questions following LDCW (n = 85) at baseline, or at Ն1 follow-up (n = 296). k N = 1683; excludes 538 taking β-blockers at Ն1 follow-up.
or leg pain interfered with work and level of dissatisfaction with current back or leg pain symptoms also improved postsurgery ( Figure 2; eTable 4 [Supplement]). Likewise, at followup, a smaller percentage of participants reported medication use for leg or back pain, leg or back pain during the LDCW, back or leg pain that prevented going to work or school, health limitations that impeded walking and mobility aid use, and were measured to have a mobility deficit, reflecting a higher percentage of participants able to complete the LDCW and faster LDCW completion time. Resting heart rate also improved ( Table 2 ). In contrast, the prevalence of severe walking limitations at year 3 was not significantly different from baseline.
At year 1, the majority of participants had clinically meaningful presurgery-to-postsurgery improvements for bodily pain (57. 
Durability of Improvement
Rates of improvement in LDCW time, knee and hip pain, knee and hip function, and mobility deficit remission did not significantly differ between year 1 and year 3 (Table 3) . However, by year 3, rates were significantly lower vs year 1 for bodily pain (48.6% [95% CI, 46.0%-51.1%]) and physical function (70.2% [95% CI, 67.8%-72.5%]) (Table 3) . Likewise, the prevalence of medication use for pain, back pain during the LDCW, health limitations to walking, and mobility aid use postsurgery increased during follow-up (Table 2) . Despite these postsurgery deteriorations in improvement, year-3 status was significantly better than baseline status.
Factors Related to Improvement in Pain, Walking Capacity, and Physical Function
Associations between sociodemographics and clinical characteristics with clinically meaningful improvements in bodily pain (SF-36 score), physical function (SF-36 score), walking capacity (LDCW completion time), and knee pain (WOMAC score) are shown in Table 4 . Associations with additional clinically meaningful improvements in hip pain, knee function and hip function (WOMAC scores), and no longer having a mobility deficit are provided in eTable 5 (in the Supplement). Younger age, higher household income, and fewer depressive symptoms presurgery, greater presurgery-to-postsurgery percent weight loss, decline in depressive symptoms, and remission or no history of diabetes were associated with greater likelihood of clinically meaningful improvements in most measures of pain and physical function. Additionally, men, as compared with women, had greater likelihood of improvement in jointspecific and bodily pain, while lower BMI and less bodily pain presurgery, greater presurgery-to-postsurgery decline in bodily pain, and remission or no history of venous edema with ulcerations were associated with greater likelihood of improvement in multiple measures of physical function. More pain presurgery was associated with higher likelihood of improvement in pain, and worse function presurgery was associated with higher likelihood of improvement in function. Type of surgical procedure (RYGB, LAGB, and other) was not related to any outcomes. The numbers of participants with clinically meaningful improvements by year, outcome, and categorical variables in Table 4 and eTable 5 (Supplement) are reported in eTable 6 and eTable7 (Supplement). 
Discussion
The primary findings of this study are that through 3 years of follow-up: (1) approximately 50% to 70% of adults with severe obesity who underwent bariatric surgery experienced clinically significant improvements in perceived bodily pain and physical function and in objectively measured walking capacity; and (2) approximately three-fourths of participants with severe knee and hip pain or disability at baseline experienced clinically significant improvements in symptoms indicative of osteoarthritis. Additionally, results of this study suggest that, while response to surgery was variable, there were several presurgery factors and postsurgery changes that were consistently associated with improvements in pain and physical function following bariatric surgery. Changes in SF-36 and WOMAC pain scores observed in this study indicate that following bariatric surgery, the majority of patients initially experience clinically meaningful improvements in bodily and joint-specific pain, although the percentage with improvement in pain and function, as measured by the SF-36, decreased from year 1 to year 3. Additionally, the findings that following surgery, a smaller percentage of patients had back or leg pain that prevented them from going to work or school and that the degree to which back or leg pain interfered with work improved suggest that bariatric surgery may lead to improvements in work productivity and related costs. However, when considering the clinical implications of bariatric surgery on pain, it is important to note that bariatric surgery patients, as a group, continue to have more pain following surgery than the general US population, as indicated by the mean standardized SF-36 bodily pain score. 16 Additionally, at year 3, approximately 1 in 3 participants took pain medication within the prior week for back pain or leg pain and were dissatisfied with their level of back or leg pain. This study revealed substantial improvements in jointspecific and general measures of function. The mean standardized SF-36 physical function score improved approximately 1 standard deviation following surgery, such that it was close to that of the general US population at year 3 (48 vs 50). 16 Improvements in resting heart rate and LDCW walking time and the related improvement (decrease) in the proportion of patients with an objectively defined mobility deficit are also noteworthy-as walking capacity is a strong predictor of incident mobility limitations and all-cause mortality. Still, at year 3, approximately one-fourth of patients self-reported limitations with walking several blocks and exhibited evidence of an objectively measured mobility deficit, indicating that a sizable portion of postsurgery patients may have walking limitations that hinder ability to follow physical activity recommendations for weight loss maintenance. 28 a All models were adjusted for site and age. Observed data are reported in eTable 3 (Supplement). b Improvement in bodily pain and physical function was evaluated among the entire cohort; LDCW time improvement was evaluated among participants who were not ineligible, refused participation, or noncompleters at any time point; improvement in knee or hip pain and function was evaluated among those with severe pain or disability at baseline; remission of mobility deficit was evaluated among those with a mobility deficit at baseline.
c Scores indicate improvement (increase) Ն5 points on the norm-based scores.
d Scores indicate improvement (decrease) of at least 24 seconds.
e Scores indicate improvement (decrease) of at least 9.7 pain points. Fifteen of 629 patients with severe or extreme knee pain or disability at baseline and 22 of 499 patients with severe or extreme hip pain or disability at baseline were excluded from analysis because their baseline score was less than 9.7 points. f Scores indicate reduction of at least 9.3 function points. Six of 627 patients with severe or extreme knee pain or disability at baseline and 8 of 493 patients with severe or extreme hip pain or disability at baseline were excluded from analysis because their baseline score was below 9.3 points.
The findings from this study reinforce shorter-term results from studies that have reported significant improvements in SF-36 bodily pain and physical function scores, [29] [30] [31] [32] WOMAC scores, 29, 33, 34 walking capacity (as measured by the LDCW or the 6-minute walk test), 30, 31, 35, 36 resting heart rate, 35, 36 or other measures of pain and function [10] [11] [12] follow-up for 145 LAGB patients for 3 to 8 years, reported that fewer patients had significant knee pain at follow-up vs baseline (38% vs 47%; P < .01). The authors speculated that the majority of patients may not have experienced a clinical improvement because of irreversible degenerative joint damage. In the Swedish Obesity Study, which primarily studied vertical banded gastroplasty, a smaller percentage of male and female surgical patients reported pain in most body parts (neck, back, hip, knee, and ankle) 2 years following surgery vs nonsurgical controls. However, most comparisons were not statistically significant at 6-year follow-up, despite substantial (albeit smaller) differences in 6-year weight change (mean difference >20 kg in both men and women). 40 Given that we detected deteriorations in some measures of pain and function between year 1 and year 3, evaluating longer-term follow-up will be important for elucidating the durability of surgeryinduced improvements and examining how weight regain, which becomes common 2 or more years following RYGB and LAGB, 8 and other factors (such as physical activity participation) may explain deteriorations. This study identifies several baseline characteristics such as younger age, higher household income, fewer depressive symptoms, and no history of diabetes related to improvements in pain and physical function following surgery, as well as presurgery-to-postsurgery changes associated with improvements in pain and function. Similar to 2 previous studies, degree of weight loss was consistently related to improvement, 29, 40 while surgical procedure, independent of weight loss, was not. However, contrary to a previous study, 29 which did not find an association between resolution of comorbid medical conditions and improvements in SF-36 or WOMAC scores 6 to 12 months following RYGB (N = 48), our data suggest that change in several comorbidities was associated with changes in pain and function. Specifically, patients who had remission of diabetes, remission of venous edema with ulcerations, and no symptoms of cardiovascular disease in the past 12 months had greater improvements in either pain, function, or both than patients who continued to have each condition and/or symptoms, respectively. Also, improvement in depressive symptoms was related to 7 of 8 outcomes.
Although this association may be bidirectional, the finding that having fewer presurgery depressive symptoms was associated with improvements in pain suggests amelioration of depressive symptoms may contribute to postsurgery pain perception. Less bodily pain presurgery and presurgery-topostsurgery decline in bodily pain were associated with improvements in physical function and walking capacity, after controlling for factors related to both pain and function. Thus, effective pain management may help postsurgical patients improve their physical function and walking capacity. Limitations of this study include the lack of a nonsurgical control group, precluding us from establishing that surgery caused observed changes in pain and physical function. Additionally, we do not know whether knee or hip pain reflected osteoarthritis pain or widespread chronic pain, and we did not assess abdominal pain, which may affect perceived joint or bodily pain, or the number of years of obesity and severe obesity, which might affect likelihood of improvement. Missing follow-up data are also a concern because they can affect statistical power or bias the findings. However, the initial sample size and retention rate were adequate to ensure sufficient power for the analyses; all longitudinal analyses controlled for baseline factors (age and site) related to missing follow-up data; and the sensitivity analysis showed that those missing pain or function outcomes at 1, 2, or 3 years vs those not missing these data had similar improvement rates at the other follow-up time points, indicating the missing data have a minimal affect on the results. The current study's large geographically diverse sample, inclusion of multiple validated measures of pain and physical function, longitudinal design, and follow-up through 3 years make it one of the most informative studies of pain and function following RYGB and LAGB to date.
Conclusions
Among a cohort of patients with severe obesity undergoing bariatric surgery, a large percentage experienced improvement compared with baseline in pain, physical function, and walk time over 3 years. However, the percentage with improvement in pain and physical function decreased between year 1 and year 3 following surgery.
